Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

1.809 +0.599 (+49.52%)
Streaming Delayed Price Updated: 10:44 AM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
CNS Pharmaceuticals (NASDAQ: CNSP) Reiterates Progress for Lead Product Candidate
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reiterates Progress for Lead Product Candidate, Addresses Recent Share Price Activity in Video to Shareholders
Via Investor Brand Network
Exposures Product Safety
CNS Pharmaceuticals Marks Milestone In Pursuit Of Berubicin Approval For GBM
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
CNS Pharmaceuticals Gives Corporate Presentation, Q&A Session
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. CNS Pharmaceuticals recently received... 
Via Benzinga
CNS Pharmaceuticals (NASDAQ: CNSP) Gives Corporate Presentation, Q&A Session
Via Investor Brand Network
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers 
Via Benzinga
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Gives Corporate Presentation, Q&A Session at Virtual Investor 2022 Top Picks Conference
Via Investor Brand Network
CNS Pharmaceuticals Announces 2021 Financial Results, Corporate Update
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. CNS Pharmaceuticals (NASDAQ: CNSP), a... 
Via Benzinga
CNS Pharmaceuticals (NASDAQ: CNSP) Announces 2021 Financial Results, Corporate Update
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 2021 Financial Results, Corporate Update
Via Investor Brand Network
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning! In preparation for another busy day of trading, we've put together a list of the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
26 Stocks Moving in Thursday's Pre-Market Session
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) rose 35% to $1.06 in pre-market trading. Kiromic BioPharma, last month, reported changes in management and board of... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Enveric Biosciences (NASDAQ:ENVB) shares increased by 12.9% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $22.... 
Via Benzinga
18 Stocks Moving in Friday's Pre-Market Session
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Have a look at this: Insiders Buying Charter Communications... 
Via Benzinga
CNS Pharmaceuticals Laying Foundation For Potentially Pivotal Global Trial
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
CNS Pharmaceuticals (NASDAQ: CNSP) Laying Foundation for Potentially Pivotal Global Trial
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Laying Robust Foundation for Potentially Pivotal Global Trial
Via Investor Brand Network
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Oncternal Therapeutics (NASDAQ:ONCT 
Via Benzinga
CNS Pharmaceuticals (NASDAQ: CNSP) Marks Milestone in Pursuit of Berubicin Approval for GBM
Via Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Marks Significant Milestone in Pursuit of Berubicin Approval for Global GBM Treatment, Raises $11.5 Million from Private Placement
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Mustang Bio (NASDAQ:MBIO) shares ... 
Via Benzinga
CNS Pharmaceuticals to Present at Virtual Investor 2022 Top Picks Conference
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. CNS Pharmaceuticals (NASDAQ: CNSP), a... 
Via Benzinga
CNS Pharmaceuticals (NASDAQ: CNSP) to Present at Virtual Investor 2022 Top Picks Conference
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at Virtual Investor 2022 Top Picks Conference
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers iSpecimen (NASDAQ:ISPC) shares rose 19.8% to $8.18 during Thursday's pre-market session. The market value of their outstanding shares is at $71.4 million. VYNE... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning, investor! We're starting off the day right with a look at the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ /... 
From JTC Team, LLC
Via AccessWire
CNS Pharmaceuticals Closes on $11.5M Private Placement
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. CNS Pharmaceuticals (NASDAQ: CNSP), a... 
Via Benzinga
CNS Pharmaceuticals (NASDAQ: CNSP) Closes on $11.5M Private Placement
Via Investor Brand Network
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.